MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MP-23-0068672
Androzenica Biopharma LLP
Androzenica Biopharma LLP - paper in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
Contribution obligation
₹1 Lakh
As per LLP agreement
Open charges
₹1.5 Cr
Secured borrowings
LLP age
4 yrs
Est. 2022
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Gwalior
ROC office
About Androzenica Biopharma LLP
Data last updated:
Androzenica Biopharma LLP is a limited liability partnership (LLP) based in Indore, Madhya Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 20 July 2022.
The LLP is registered with the Registrar of Companies (ROC), Gwalior, under LLPIN ABB-7970. Its GSTIN is 23ABZFA0552B1ZQ (Madhya Pradesh).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Shailendra Mandloi and Mitulkumar Sureshbhai Zala.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per MCA filings, the LLP has open charges of ₹1.5 Cr on record.
Androzenica Biopharma LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0068672).
Company details
LLPIN ABB-7970
Incorporation Date 20 July 2022
Total Obligation of Contribution ₹1 Lakh
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0068672
Recognitions & Rankings of Androzenica Biopharma
Contact details
Androzenica Biopharma LLP's registered office is in Indore, Madhya Pradesh.
- Registered Address539 Scheme 78 Part – 1 Phase – 2, Near New Loha Mandi Dewas Naka, Indore, Madhya Pradesh, India – 452010
- IndustryPaper, Paper & Paper Products, Manufacturing
Comprehensive company report
Androzenica Biopharma LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Androzenica Biopharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | |||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | |||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Androzenica Biopharma LLP, buy the company report.
Designated partners of Androzenica Biopharma LLP
Androzenica Biopharma has 2 designated partners on record. No former designated partners are listed.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailendra Mandloi | Designated Partner | 20 Jul 2022 | 4 Years 3 Months | Current |
| Mitulkumar Sureshbhai Zala | Designated Partner | 20 Jul 2022 | 4 Years 3 Months | Current |
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jan 2023 | 100668427 | Hdfc Bank Limited | ₹1.5 Cr | Open |
To see the full charge records of Androzenica Biopharma LLP, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Androzenica Biopharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Androzenica Biopharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Androzenica Biopharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABZFA0552B1ZQ | Madhya Pradesh | Active | 17 Oct 2022 |
To see the full GST registrations and return filing status of Androzenica Biopharma LLP, buy the company report.
Recent activity
Androzenica Biopharma LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Mitulkumar Sureshbhai Zala was appointed as Designated Partner on 20 Jul 2022.
AGM
Androzenica Biopharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Androzenica Biopharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Hdfc Bank Limited of Rs. 150.00 Lakh registered on 03 Jan 2023 with Charge ID 100668427 was modified on 12 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 150.00 Lakh with Charge ID 100668427 was registered on 03 Jan 2023.
Appointed
Mitulkumar Sureshbhai Zala was appointed as Designated Partner.
Appointed
Shailendra Mandloi was appointed as Designated Partner.
Incorporation
20 Jul 2022
Androzenica Biopharma Llp was registered on 20 Jul 2022 with Roc Gwalior & aged 4 years 3 months as per MCA records.
Frequently asked questions
Androzenica Biopharma is an active limited liability partnership based in Indore, Madhya Pradesh, India. The LLP works in paper and paper products, within the paper industry. It was incorporated on 20 July 2022 (4+ years old) and is registered under LLPIN ABB-7970.
Androzenica Biopharma has 2 current designated partners:
- Shailendra Mandloi - Designated Partner
- Mitulkumar Sureshbhai Zala - Designated Partner
The latest financial statements of Androzenica Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Androzenica Biopharma is 23ABZFA0552B1ZQ, registered in Madhya Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Androzenica Biopharma is ABB-7970. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Androzenica Biopharma was incorporated on 20 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
Mitulkumar Sureshbhai Zala was appointed as Designated Partner on 20 Jul 2022. Shailendra Mandloi was appointed as Designated Partner on 20 Jul 2022.
Yes, Androzenica Biopharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0068672).
The registered office of Androzenica Biopharma is at 539 Scheme 78 Part – 1 Phase – 2, Near New Loha Mandi Dewas Naka, Indore, Madhya Pradesh, India – 452010.
Androzenica Biopharma operates in the paper industry, in the paper and paper products segment.